Dementia in 2010: Paving the way for Alzheimer disease drug development

Nature Reviews Neurology

Volumn 7, Issue 2, 2011, Pages 65-66

  Blennow, Kaj ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN ANTIBODY; AMYLOID BETA PROTEIN[1-42]; BAPINEUZUMAB; BIOLOGICAL MARKER; GAMMA SECRETASE; HOMOTAURINE; PLACEBO; TARENFLURBIL; TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; DISEASE COURSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; HUMAN; LONG TERM POTENTIATION; MEMORY DISORDER; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PUBLICATION; SHORT SURVEY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; DRUG DISCOVERY; HUMANS; PROTEINS;

EID: 79751508275     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2010.214     Document Type: Short Survey

References (8)

1. Fukumoto, H. et al. High-molecular-weight β-amyloid oligomers are elevated in cerebrospinal fluid of alzheimer patients. FASEB J. 24, 2716-2726 (2010).
2. Shankar, G. M. et al. amyloid-β protein dimmers isolated directly from alzheimer s brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842 (2008).
3. He, G. et al. Gamma-secretase activating protein is a therapeutic target for alzheimer s disease. Nature 467, 95-98 (2010).
4. Blennow, K., de Leon, M. J. & Zetterberg, H. alzheimer s disease. Lancet 368, 387-403 (2006).
5. rinne, J. O. et al. 11C-PiB PeT assessment of change in fibrillar amyloid-β load in patients with alzheimer s disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol. 9, 363-372 (2010).
6. Hampel, H. et al. Biomarkers for alzheimer s disease: academic, industry and regulatory perspectives. Nat. Rev. Drug Discov. 9, 560-574 (2010).
7. Dubois, B. et al. research criteria for the diagnosis of alzheimer s disease: revising the ninCDS-aDrDa criteria. Lancet Neurol. 6, 734-746 (2007). (Pubitemid 47058377)
8. Dubois, B. et al. revising the definition of alzheimer s disease: a new lexicon. Lancet Neurol. 9, 1118-1127 (2010).